In tumor studies, FDX1 has been found to affect prognosis and mediate glucose metabolism, fatty acid oxidation and amino acid metabolism in lung adenocarcinoma, as well as to influence alterations in major pathways in renal cell carcinoma [39, 40]. This evidence concerns the gene FDX1 and hereditary clear cell renal cell carcinoma.